Indication

Lialda is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC) and for the maintenance of remission of UC.

Important Safety Information

  • You should not take Lialda if you are allergic to salicylates (including mesalamine, aspirin, or aspirin-containing products) or to any of the ingredients of Lialda.
  • Reports of problems with kidney function have been associated with mesalamine-containing products like Lialda. Tell your doctor if you have or have had problems with your kidneys. It is recommended that all patients have their kidney function checked before starting Lialda and periodically while on therapy.

Read more

Indication

Lialda is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC) and for the maintenance of remission of UC.

Important Safety Information

  • You should not take Lialda if you are allergic to salicylates (including mesalamine, aspirin, or aspirin-containing products) or to any of the ingredients of Lialda.
  • Reports of problems with kidney function have been associated with mesalamine-containing products like Lialda. Tell your doctor if you have or have had problems with your kidneys. It is recommended that all patients have their kidney function checked before starting Lialda and periodically while on therapy.
Read more

Site Map

Important Safety Information (cont'd)

  • Products that contain mesalamine, like Lialda, have been associated with a condition that may be difficult to distinguish from an ulcerative colitis flare-up. Symptoms include cramping, stomach ache, bloody diarrhea, fever, headache, and rash. If you experience any of these symptoms, talk to your doctor immediately. Your doctor may decide to discontinue your medication.
  • Tell your doctor if you are allergic to sulfasalazine, as you may also be allergic to Lialda or drugs that contain or are converted to mesalamine. Some patients taking Lialda or mesalamine-containing products have reported heart-related allergic reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart. Tell your doctor if you have or have had a history of myocarditis or pericarditis as this may increase your likelihood of having these types of reactions.
  • Reports of liver failure have been associated with mesalamine-containing products like Lialda in patients that have or have had liver disease. Tell your doctor if you have a problem with your liver.
  • Tell your doctor if you have a stomach blockage, as this may delay the release of medication.
  • In clinical trials, common side effects reported with Lialda included ulcerative colitis, headache, gas, abnormal liver function test results, and stomach ache. Inflammation of the pancreas was reported which led to discontinuation of Lialda therapy. Other side effects may occur.
  • Before starting Lialda, tell your doctor about all medications you are taking. Mesalamine may increase the risk of kidney problems when used with non-steroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen, naproxen). Mesalamine may increase the risk of blood disorders when used with azathioprine and 6-mercaptopurine.

Please see Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.

 
You are about to leave the Lialda® (mesalamine) Web site.
This link will take you to a Web site maintained by a third party, who is responsible for its content and privacy policy. Shire provides this link as a service to you. Our privacy policy does not apply to the Web site you are about to visit. We encourage you to read the privacy policy of every Web site you visit. Click Cancel to return to Lialda.com or OK to continue.
The information contained in this section of the site is intended for US health care professionals only. Click OK if you are a health care professional.
Ok Cancel
E-mail this page or Web site to a friend or loved one by filling out the form below. All fields are required.
E-mail this page only

Please select one.

E-mail this site
*Your First Name
Please enter your first name.
*Recipient’s First Name
Please enter the recipient’s first name.
*Your E-mail Address
Please enter a valid e-mail address.
*Recipient’s E-mail Address
Please enter a valid recipient’s e-mail address.

Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes. Please click here to review our privacy policy.

Your e-mail has been sent.
E–mail this list of questions for the doctor — to yourself, a friend or a loved one — by filling out the form below. Fields marked with an asterisk (*) are required.
*Your First Name
Please enter your first name.
*Recipient’s First Name
Please enter the recipient’s first name.
*Your E-mail Address
Please enter a valid e-mail address.
*Recipient’s E-mail Address
Please enter a valid recipient’s e-mail address.

Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes. Please click here to review our privacy policy.

Your e-mail has been sent.
We’re glad you’ve decided to continue with the Connect 2 More program. Please enter the information below to re-confirm your registration.
*Required
*Identification Number
Please enter a valid Idenfication Number.
 
Please enter the Identification Number located at the top right side of the letter you received.
*E-mail
Please enter a valid e-mail address.
 
Many of our communications are available as e-mails including newsletters, reminders, and coupon offers.